Clinical Trial: A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07136805) titled 'A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis' on Aug. 15.

Brief Summary: This is a multicenter, randomized, single-masked, active-controlled, parallel, Phase III pivotal study in China

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Non-infectious Anterior Uveitis

Intervention: DRUG: VVN461 Ophthalmic Solution 1.0%

1 drop for study eye each time, 6 times daily (Q2h) for 7 days; 4 times daily (QID) for 7 days; 2 times daily (BID) for 7 days; 1 time daily for 7 days

DRUG: 1.0% prednisolone acetate

1 drop for study eye each time, 6 times daily (Q2h) for 7 days; 4 times daily ...